IMMUNOTHERAPY
Clinical trials for IMMUNOTHERAPY explained in plain language.
Never miss a new study
Get alerted when new IMMUNOTHERAPY trials appear
Sign up with your email to follow new studies for IMMUNOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radiation plus new drugs: can they work together against advanced cancer?
Disease control CompletedThis study looked at whether combining newer immunotherapy drugs with palliative radiation is safe for people with advanced cancer. Researchers followed 42 patients who received both treatments to manage cancer symptoms like pain or breathing problems. The main goal was to check …
Matched conditions: IMMUNOTHERAPY
Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
First human test: can your own immune cells fight advanced cancer?
Disease control CompletedThis early-stage study tested the safety of a personalized immunotherapy for people with advanced solid tumors. Doctors collected immune cells from patients' tumors, grew more of them in a lab, and then reinfused them back into 43 participants to see if they could fight the cance…
Matched conditions: IMMUNOTHERAPY
Phase: PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New drug combo aims to shrink tumors before lung cancer surgery
Disease control CompletedThis study tested whether adding the immunotherapy drug serplulimab to standard chemotherapy, given both before and after surgery, could help people with operable non-small cell lung cancer. The goal was to see if this combination could shrink tumors more effectively before surge…
Matched conditions: IMMUNOTHERAPY
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New strategy tested to overcome resistance to melanoma immunotherapy
Disease control CompletedThis study tested a two-step approach for patients with advanced melanoma that did not respond to standard immunotherapy. First, patients received a chemotherapy drug (DTIC). Then, they tried immunotherapy again. The goal was to see if the chemotherapy could 'reset' the tumor and…
Matched conditions: IMMUNOTHERAPY
Phase: PHASE2 • Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New hope to avoid permanent colostomy bags? trial tests combo therapy for tough rectal cancers
Disease control CompletedThis study tested whether adding an immunotherapy drug to the standard pre-surgery treatment (chemotherapy and radiation) could improve results for patients with a specific type of ultra-low rectal cancer. It involved 201 patients who were randomly assigned to receive either the …
Matched conditions: IMMUNOTHERAPY
Phase: PHASE2, PHASE3 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
Scientists track heart risks in pioneering cancer treatment
Knowledge-focused CompletedThis study aimed to understand how CAR-T cell therapy, a powerful cancer treatment, affects the heart. Researchers followed 44 adults with leukemia or lymphoma, checking their heart function with scans and blood tests before and after treatment. The goal was to learn how often he…
Matched conditions: IMMUNOTHERAPY
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:37 UTC